Khadizhat G. Zaynalabidova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Khadizhat G. Zaynalabidova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
A.A. Avdeeva
Paediatric Research and Clinical Centre for Infectious Diseases (Saint-Petersburg, Russia)
1 shared publication- Alla Andreeva
Smolensk Regional Clinical Hospital, 214018 Smolensk, Russia
1 shared publication - Anastasiia Dushina
National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)
1 shared publication E.S. Larin
War Veterans Hospital No. 3 (Moscow, Russia)
1 shared publicationL.V. Fedina
City Clinical Hospital named after S.S. Yudin (Moscow, Russia)
1 shared publication- Olga Domanskaya
Kuzbas Children’s Clinical Hospital n.a. Professor Y.E. Malachovskiy, 654063 Novokuznetsk, Russia
1 shared publication
Latest Publications
- Open Access
- 28 December 2025
- Published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy in Clinical Microbiology and Antimicrobial Chemotherapy
- Vol. 27 (3) , 289-303
Hypervirulent Klebsiella pneumoniae infections: relevance of the problem
Klebsiella pneumoniae is one of the most common pathogens causing community-acquired and nosocomial infections in hospitalized patients. Among the two known pathotypes, hypervirulent (hvKp) has become a matter of serious concern, as such isolates can cause unusual infections in terms of their location and course (multiple foci and/or subsequent metastatic spread) in previously healthy individuals. Currently, infections caused by hvKp are detected everywhere. Of even greater concern is the convergence of hypervirulence and multiple antibiotic resistance in K. pneumoniae. This review outlines epidemiological data on the prevalence of hvKp, describes the hypervirulent pathotype in comparison with the classical one in terms of virulence factor expression and clinical manifestations. The modern approaches to the diagnosis of infections caused by hvKp, current and promising treatment, and the possibilities for specific prevention are also discussed.
- 28 December 2025
- Published by Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy in Clinical Microbiology and Antimicrobial Chemotherapy
- Vol. 27 (3) , 289-303
Open AccessHypervirulent Klebsiella pneumoniae infections: relevance of the problem
Klebsiella pneumoniae is one of the most common pathogens causing community-acquired and nosocomial infections in hospitalized patients. Among the two known pathotypes, hypervirulent (hvKp) has become a matter of serious concern, as such isolates can cause unusual infections in terms of their location and course (multiple foci and/or subsequent metastatic spread) in previously healthy individuals. Currently, infections caused by hvKp are detected everywhere. Of even greater concern is the convergence of hypervirulence and multiple antibiotic resistance in K. pneumoniae. This review outlines epidemiological data on the prevalence of hvKp, describes the hypervirulent pathotype in comparison with the classical one in terms of virulence factor expression and clinical manifestations. The modern approaches to the diagnosis of infections caused by hvKp, current and promising treatment, and the possibilities for specific prevention are also discussed.
- Open Access
- 7 July 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (7) , 1162
Assessment of Antimicrobial Consumption in Multi-Field Hospitals with Pediatric Inpatients: Conventional vs. Novel Pediatric-Adjusted Methodologies
Background: the objective of this study was to propose a methodology for the assessment of antimicrobial consumption (AMC) in pediatric inpatients and to estimate variances in consumption levels in multi-field hospitals with pediatric inpatients, calculated by means of the pediatric-adjusted methodology vs. the conventional methodology. Methods: the pediatric-adjusted methodology based on the conventional ATC/DDD method and children’s DDDs (cDDD) for antimicrobials were proposed and validated in a series of probabilistic sensitivity analyses of real clinical data extracted from the receipt notes of three multi-field hospitals. Differences in AMC in multi-field hospitals with pediatric inpatients, calculated by means of the proposed methodology vs. the conventional methodology, were assessed for a virtual cohort of inpatients, with the pediatric share increasing by 1%. Results: in children ≤12 years old, assessment by the standard methodology resulted in a 59% underestimation of AMC from the levels based on prescribed doses, vs. a 25% underestimation for the proposed methodology. In a mixed-age virtual population of inpatients, the underestimation of consumption levels rose to 321% for the ATC/DDD methodology compared to the proposed one. Conclusions: the proposed methodology demonstrated a higher accuracy of AMC estimates compared to the conventional one and can be considered for the quantification of antimicrobial utilization in pediatric institutions and multi-field hospitals with a substantial share of pediatric inpatients.
- 7 July 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (7) , 1162
Open AccessAssessment of Antimicrobial Consumption in Multi-Field Hospitals with Pediatric Inpatients: Conventional vs. Novel Pediatric-Adjusted Methodologies
Background: the objective of this study was to propose a methodology for the assessment of antimicrobial consumption (AMC) in pediatric inpatients and to estimate variances in consumption levels in multi-field hospitals with pediatric inpatients, calculated by means of the pediatric-adjusted methodology vs. the conventional methodology. Methods: the pediatric-adjusted methodology based on the conventional ATC/DDD method and children’s DDDs (cDDD) for antimicrobials were proposed and validated in a series of probabilistic sensitivity analyses of real clinical data extracted from the receipt notes of three multi-field hospitals. Differences in AMC in multi-field hospitals with pediatric inpatients, calculated by means of the proposed methodology vs. the conventional methodology, were assessed for a virtual cohort of inpatients, with the pediatric share increasing by 1%. Results: in children ≤12 years old, assessment by the standard methodology resulted in a 59% underestimation of AMC from the levels based on prescribed doses, vs. a 25% underestimation for the proposed methodology. In a mixed-age virtual population of inpatients, the underestimation of consumption levels rose to 321% for the ATC/DDD methodology compared to the proposed one. Conclusions: the proposed methodology demonstrated a higher accuracy of AMC estimates compared to the conventional one and can be considered for the quantification of antimicrobial utilization in pediatric institutions and multi-field hospitals with a substantial share of pediatric inpatients.